X. Jia

A single-arm, multicenter, safety-monitoring, phase IV study of icotinib in treating advanced non-small cell lung cancer (NSCLC).

B. Han, Yiping Zhang, Shucai Zhang, 2014, Lung cancer.

Safety and efficacy results of a phase IV, open-label, multicenter, safety-monitoring study of icotinib in treating advanced non-small cell lung cancer (NSCLC): ISAFE study.

Yiping Zhang, Shucai Zhang, K. Ying, 2013 .